Brian Gorman - 05 Jan 2023 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
General Counsel
Signature
/s/ Brian Gorman
Issuer symbol
N/A
Transactions as of
05 Jan 2023
Net transactions value
-$26,523
Form type
4
Filing time
05 Jan 2023, 15:59:40 UTC
Previous filing
15 Jul 2022
Next filing
31 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Sale $26,523 -1,313 -3.9% $20.20 32,434 05 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.